A case for regulatory B cells

Journal of Immunology

Volumn 176, Issue 2, 2006, Pages 705-710

  Mizoguchi, Atsushi ^a   Bhan, Atul K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; CELL FUNCTION; CELL INTERACTION; CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; ENTERITIS; IMMUNE RESPONSE; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SHORT SURVEY;

EID: 30744458329     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.2.705     Document Type: Short Survey

References (104)

1. Chen, Y., V. K. Kuchroo, J. Inobe, D. A. Hafler, and H. L. Weiner. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265: 1237-1240.
2. + T cell subset inhibits antigen-specific T cell responses and prevents colitis. Nature 389: 737-742.
3. Shevach, E. M. 2000. Regulatory T cells in auto immunity. Ann. Rev. Immunol. 18: 423-449.
4. Sakaguchi, S. 2001. Policing the regulators. Nat. Immunol. 2: 283-284.
5. Coombes, J. L., N. J. Robinson, K. J. Maloy, H. H. Uhlig, and F. Powrie. 2005. Regulatory T cells and intestinal homeostasis. Immunol. Rev. 204: 184-194.
6. Nagler-Anderson, C., A. K. Bhan, D. K. Podolsky, and C. Terhorst. 2004. Control freaks: immune regulatory cells. Nat. Immunol. 5: 119-122.
7. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Ann. Rev. Immunol. 22: 531-562.
8. Murakami, M., and T. Honjo. 1997. Transgenic mouse models for B cell dominant autoimmune diseases. Curr. Opin. Immunol. 9: 846-850.
9. Fields, M. L., and J. Erikson. 2003. The regulation of lupus-associated autoantibodies: immunoglobulin transgenic models. Curr. Opin. Immunol. 15: 709-717.
10. Korganow, A. S., H. Ji, S. Mangialaio, V. Duchatelle, R. Pelanda, T. Martin, C. Degott, H. Kikutani, K. Rajewsky, J. L. Pasquali, et al. 1999. From systemic T cell self-reactivity to organ-specific auroimmune disease via immunoglobulins. Immunity 10: 451-461.
11. Martin, F., and A. C. Chan. 2004. Pathogenic roles of B cells in human auroimmunity: insights from the clinic. Immunity 20: 517-527.
12. Wolf, S. D., B. N. Dittel, F. Hardardottir, and C. A. Janeway, Jr. 1996. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 184: 2271-2278.
13. Fillatreau, S., C. H. Sweenie, M. J. McGeachy, D. Gray, and S. M. Anderton. 2002. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3: 944-950.
14. Bhan, A. K., E. Mizoguchi, R. N. Smith, and A. Mizoguchi. 1999. Colitis in transgenic and knockout animals as models of human inflammatory bowel disease. Immunol. Rev. 169: 195-207.
15. Strober, W., I. J. Fuss, and R. S. Blumberg. 2002. The immunology of mucosal models of inflammation. Ann. Rev. Immunol. 20: 495-549.
16. Mizoguchi, E., R. J. Xavier, H. C. Reinecker, H. Uchino, A. K. Bhan, D. K. Podolsky, and A. Mizoguchi. 2003. Colonic epithelial functional phenotype varies with type and phase of experimental colitis. Gastroenterology 125: 148-161.
17. Targan, S. R. 1998. The search for pathogenic antigens in ulcerative colitis. Gastroenterology 114: 1099-1100.
18. Mombaerts, P., E. Mizoguchi, M. J. Grusby, L. H. Glimcher, A. K. Bhan, and S. Tonegawa. 1993. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 75: 274-282.
19. + T cells. Nature 369: 654-658.
20. Mizoguchi, A., E. Mizoguchi, C. Chiba, G. M. Spiekermann, S. Tonegawa, C. Nagler-Anderson, and A. K. Bhan. 1996. Cytokine imbalance and autoantibody production in T cell receptor α mutant mice with inflammatory bowel disease. J. Exp. Med. 183: 847-856.
21. Mizoguchi, A., E. Mizoguchi, R. N. Smith, F. I. Preffer, and A. K. Bhan. 1997. Suppressive role of B cells in chronic colitis of T cell receptor α mutant mice. J. Exp. Med. 186: 1749-1756.
22. Mizoguchi, E., A. Mizoguchi, F. I. Preffer, and A. K. Bhan. 2000. Regulatory role of mature B cells in a murine model of inflammatory bowel disease. Int. Immunol. 12: 597-605.
23. Mizoguchi, A., E. Mizoguchi, H. Takedatsu, R. S. Blumberg, and A. K. Bhan. 2002. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d up-regulation. Immunity 16: 219-230.
24. Okkenhaug, K., A. Bilancio, G. Farjot, H. Priddle, S. Sancho, E. Peskett, W. Pearce, S. E. Meek, A. Salpekar, M. D. Waterfield, et al. 2002. Impaired B and T cell antigen receptor signaling in p110δ PI 3-kinase mutant mice. Science 297: 1031-1034.
25. Fernandez, M. I., T. Pedron, R. Tournebize, J. C. Olivo-Marin, P. J. Sansonetti, and A. Phalipon. 2003. Ann-inflammatory role for intracellular dimeric immunoglobulin a by neutralization of lipopolysaccharide in epithelial cells. Immunity 18: 739-749.
26. Gerth, A. J., L. Lin, M. F. Neurath, L. H. Glimcher, and S. L. Peng. 2004. An innate cell-mediated, murine ulcerative colitis-like syndrome in the absence of nuclear factor of activated T cells. Gastroenterology 126: 1115-1121.
27. + T cells with an epithelial cell lectin, galectin-4, contributes to exacerbation of intestinal inflammation. Immunity 20: 681-693.
28. Su, T. T., B. Guo, B. Wei, J. Braun, and D. J. Rawlings. 2004. Signaling in transitional type 2 B cells is critical for peripheral B cell development. Immunol. Rev. 197: 161-178.
29. Dalwadi, H., B. Wei, M. Schrage, K. Spicher, T. T. Su, L. Birnbaumer, D. J. Rawlings, and J. Braun. 2005. B cell developmental requirement for the Gαi2 gene. J. Immunol. 170: 1707-1715.
30. Wei, B., P. Velazquez, O. Turovskaya, K. Spricher, R. Aranda, M. Kronenberg, L. Birnbaumer, and J. Braun. 2005. Mesenteric B cells centrally inhibit CD4 T cell colitis through interaction with regulatory T cell subsets. Proc. Natl. Acad. Sci. USA 102: 2010-2015.
31. Ostanin, D. V., K. P. Pavlick, S. Bharwani, D. D'Souza, K. L. Furr, C. M. Brown, and M. B. Grisham. 2005. T cell-induced inflammation of the small and large intestine in immunodeficient mice. Am. J. Physiol. In press.
32. Sakaguchi, S., and N. Sakaguchi. 1990. Thymus and autoimmunity: capacity of the normal thymus to produce pathogenic self-reactive T cells and conditions required for their induction of autoimmune disease. J. Exp. Med. 172: 537-545.
33. + regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J. Immunol. 168: 5979-5983.
34. + T cells induce or protect from chronic intestinal inflammation in C.B-17 scid mice. Int. Immunol. 5: 1461-1471.
35. Yan, J., and M. J. Mamula. 2002. B and T cell tolerance and autoimmunity in autoantibody transgenic mice. Int. Immunol. 14: 963-971.
36. Mauri, C., D. Gray, N. Mushtaq, and M. Londei. 2003. Prevention of arthritis by interleukin 10-producing B cells. J. Exp. Med. 197: 489-501.
37. Brummel, R., and P. Lenett. 2005. Activation of marginal zone B cells from lupus mice with type A(D) CpG-oligodeoxynucleotides. J. Immunol. 174: 2429-2434.
38. Lenert, P., R. Brummel, E. H. Field, and R. F. Ashman. 2005. TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production. J. Clin. Immunol. 25: 29-40.
39. Ji, H., K. Ohmura, U. Mahmood, D. M. Lee, F. M. Hofhuis, S. A. Boackle, K. Takahashi, V. M. Holers, M. Walport, C. Gerard, et al. 2002. Arthritis critically dependent on innate immune system players. Immunity 16: 157-168.
40. + regulatory cells within the central nervous system. J. Immunol. 175: 3025-3032.
41. Harris, D. P., L. Haynes, P. C. Sayles, D. K. Duso, S. M. Eaton, N. M. Lepak, L. L. Johnson, S. L. Swain, and F. E. Lund. 2000. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat. Immunol. 1: 475-482.
42. Harris, D. P., S. Goodrich, A. J. Gerth, S. L. Peng, and F. E. Lund. 2005. Regulation of IFN-γ production by B effector 1 cells: essential roles for T-bet and the IFN-γ receptor. J. Immunol. 174: 6781-6790.
43. Fiorentino, D. F., A. Zlotnik, T. R. Mosmann, M. Howard, and A. O'Garra. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147: 3815-3822.
44. O'Farrell, A. M., Y. Liu, K. W. Moore, and A. L. Mui. 1998. IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways. EMBO J. 17: 1006-1018.
45. Grunig, G., D. B. Corry, M. W. Leach, B. W. Seymour, V. P. Kurup, and D. M. Rennick. 1997. Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J. Exp. Med. 185: 1089-1099.
46. Pestka, S., C. D. Krause, D. Sarkar, M. R. Walter, Y. Shi, and P. B. Fisher. 2004. Interleukin-10 and related cytokines and receptors. Ann. Rev. Immunol. 22: 929-979.
47. Gonnella, P. A., H. P. Waldner, and H. L. Weiner. 2001. B cell-deficient (μMT) mice have alterations in the cytokine microenvironment of the gut-associated lymphoid tissue (GALT) and a defect in the low dose mechanism of oral tolerance. J. Immunol. 166: 4456-4464.
48. Mangan, N. E., R. E. Fallon, P. Smith, N. van Rooijen, A. N. McKenzie, and P. G. Fallon. 2004. Helminth infection protects mice from anaphylaxis via IL-10-producing B cells. J. Immunol. 173: 6346-6356.
49. Gillan, V., R. A. Lawrence, and E. Devaney. 2005. B cells play a regulatory role in mice infected with the L3 of Brugia pahangi. Int. Immunol. 17: 373-382.
50. Zanin-Zhorov, A., G. Tal, S. Shivtiel, M. Cohen, T. Lapidot, G. Nussbaum, R. Margalit, I. R. Cohen, and O. Lider. 2005. Heat shock protein 60 activates cytokine-associated negative regulator suppressor of cytokine signaling 3 in T cells: effects on signaling, chemotaxis, and inflammation. J. Immunol. 175: 276-285.
51. Duddy, M. E., A. Alter, and A. Bar-Or. 2004. Distinct profiles of human B cell effector cytokines: a role in immune regulation? J. Immunol. 172: 3422-3427.
52. Sartor, R. B. 2004. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 126: 1620-1633.
53. Byrne, S. N., and G. M. Halliday. 2005. B cells activated in lymph nodes in response to ultraviolet irradiation or by interleukin-10 inhibit dendritic cell induction of immunity. J. Invest. Dermatol. 124: 570-578.
54. Tian, J., D. Zekzer, L. Hanssen, Y. Lu, A. Olcort, and D. L. Kaufman. 2005. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J. Immunol. 167: 1081-1089.
55. + T cells: role of TGF-β1. J. Immunol. 170: 5897-5911.
56. Serreze, D. V., H. D. Chapman, D. S. Varnum, M. S. Hanson, P. C. Reifsnyder, S. D. Richard, S. A. Fleming, E. H. Leirer, and L. D. Shultz. 1996. B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice. J. Exp. Med. 184: 2049-2053.
57. Falcone, M., J. Lee, G. Parstone, B. Yeung, and N. Sarvetnick. 2005. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice. J. Immunol. 161: 1l63-1168.
58. O'Garra, A., R. Chang, N. Go, R. Hastings, G. Haughton, and M. Howard. 1992. Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur. J. Immunol. 22: 711-717.
59. Hardy, R. R., and K. Hayakawa. 2001. B cell development pathways. Ann. Rev. Immunol. 19: 595-621.
60. + B cells control the IL-12-dependent Th1-priming capacity of neonatal DCs. Immunity 22: 467-477.
61. Carvalho, T. L., T. Mota-Santos, A. Cumano, J. Demengeot, and P. Vieira. 2001. Arrested B lymphopoiesis and persistence of activated B cells in adult interleukin 7(-/)- mice. J. Exp. Med. 194: 1141-1150.
62. + APC in mouse spleen. J. Immunol. 173: 2362-2372.
63. Wells, S. M., A. B. Kantor, and A. M. Stall. 1994. CD43 (S7) expression identifies peripheral B cell subsets. J. Immunol. 153: 5503-5515.
64. Pillai, S., A. Cariappa, and S. T. Moran. 2005. Marginal zone B cells. Annu. Rev. Immunol. 23: 161-196.
65. Allman, D., B. Srivastava, and R. C. Lindsley. 2004. Alternative routes to maturity: branch points and pathways for generating follicular and marginal zone B cells. Immunol. Rev. 197: 147-160.
66. Mizoguchi, A., E. Mizoguchi, and A. K. Bhan. 2003. Immune networks in animal models of inflammatory bowel disease. Inflamm. Bowel Dis. 9: 246-259.
67. Rudolph, U., M. J. Finegold, S. S. Rich, G. R. Harriman, Y. Srinivasan, P. Brabet, G. Boulay, A. Bradley, and L. Birnbaumer. 1995. Ulcerative colitis and adenocarcinoma of the colon in Gαi2-deficient mice. Nat. Genet. 10: 143-150.
68. Hampe, J., N. J. Lynch, S. Daniels, S. Bridger, A. J. Macpherson, P. Stokkers, A. Forbes, J. E. Lennard-Jones, C. G. Mathew, M. E. Curran, and S. Schreiber. 2001. Fine mapping of the chromosome 3p susceptibility locus in inflammatory bowel disease. Gut 48: 191-197.
69. Cho, J. H., D. L. Nicolae, R. Ramos, C. T. Fields, K. Rabenau, S. Corradino, S. R. Brant, R. Espinosa, M. LeBeau, S. B. Hanauer, et al. 2000. Linkage and linkage disequilibrium in chromosome band 1p36 in American Chaldeans with inflammatory bowel disease. Hum. Mol. Genet. 9: 1425-1432.
70. Di Sabatino, A., M. M. Rosado, R. Ciccocippo, P. Cazzola, R. Morera, G. R. Corazza, and R. Carsetti. 2005. Depletion of immunoglobulin M memory B cells is associated with splenic hypofunction in inflammatory bowel disease. Am. J. Gastroenterol. 100: 1788-1795.
71. Casola, S., K. L. Otipoby, M. Alimzhanov, S. Humme, N. Uyttersprot, J. L. Kutok, M. C. Carroll, and K. Rajewsky. 2004. B cell receptor signal strength determines B cell fate. Nat. Immunol. 5: 317-327.
72. Li, Y., H. Li, and M. Weigert. 2002. Autoreactive B cells in the marginal zone that express dual receptors. J. Exp. Med. 195: 181-188.
73. Thien, M., T. G. Phan, S. Gardam, M. Amesbury, A. Basten, F. Mackay, and R. Brink. 2004. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity 20: 785-798.
74. Lopes-Carvalho, T., J. Foote, and J. F. Kearney. 2005. Marginal zone B cells in lymphocyte activation and regulation. Curr. Opin. Immunol. 17: 244-250.
75. Zeng, D., M. K. Lee, J. Tung, A. Brendolan, and S. Strober. 2000. Cutting edge: a role for CD1 in the pathogenesis of lupus in NZB/NZW mice. J. Immunol. 164: 5000-5004.
76. Amano, H., E. Amano, T. Moll, D. Marinkovic, N. Ibnou-Zekri, E. Martinez-Soria, I. Semac, T. Wirth, L. Nitschke, and S. Izui. 2003. The Yaa mutation promoting murine lupus causes defective development of marginal zone B cells. J. Immunol. 170: 2293-2301.
77. Rakoff-Nahoum, S., J. Paglino, F. Eslami-Varzaneh, S. Edberg, and R. Medzhitov. 2004. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118: 229-241.
78. Fukata, M., K. S. Michelsen, R. Eri, L. S. Thomas, B. Hu, K. Lukasek, C. C. Nast, J. Lechago, R. Xu, Y. Naiki, et al. 2005. Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am. J. Physiol 288: G1055-G1065.
79. Rachmilewitz, D., F. Karmeli, K. Takabayashi, T. Hayashi, L. Leider-Trejo, J. Lee, L. M. Leoni, and E. Raz. 2002. Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis. Gastroenterology 122: 1428-1441.
80. Rachmilewitz, D., K. Katakura, F. Karmeli, T. Hayashi, C. Reinus, B. Rudensky, S. Akira, K. Takeda, J. Lee, K. Takabayashi, and E. Raz. 2004. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 126: 520-528.
81. Schultze, J. L., S. Michalak, J. Lowne, A. Wong, M. H. Gilleece, J. G. Gribben, and L. M. Nadler. 1999. Human non-germinal center B cell interleukin (IL)-12 production is primarily regulated by T cell signals CD40 ligand, interferon γ, and IL-10: role of B cells in the maintenance of T cell responses. J. Exp. Med. 189: 1-12.
82. Knoechel, B., J. Lohr, E. Kahn, and A. K. Abbas. 2005. The link between lymphocyte deficiency and autoimmunity; roles of endogenous T and B lymphocytes in tolerance. J. Immunol. 175:21-26.
83. Tsitoura, D. C., V. P. Yeung, R. H. DeKruyff, and D. T. Umetsu. 2002. Critical role of B cells in the development of T cell tolerance to aeroallergens. Int. Immunol. 14: 659-667.
84. Moulin, V., F. Andris, K. Thielemans, C. Maliszewski, J. Urbain, and M. Moser. 2000. B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation. J. Exp. Med. 192: 475-482.
85. Yu, P., Y. Wang, R. K. Chin, L. Martinez-Po mares, S. Gordon, M. H. Kosco-Vibois, J. Cyster, and Y. X. Fu. 2002. B cells control the migration of a subset of dendritic cells into B cell follicles via CXC chemokine ligand 13 in a lymphotoxin-dependent fashion. J. Immunol. 168: 5117-5123.
86. + regulatory T cells in the lamina propria of patients with inflammatory bowel disease. J. Immunol. 174: 5814-5822.
87. Shibolet, O., Y. Kalish, A. Klein, R. Alper, L. Zolotarov, B. Thalenfeld, D. Engelhardt, E. Rabbani, and Y. Ilan. 2004. Adoptive transfer of ex vivo immune-programmed NKT lymphocytes alleviates immune-mediated colitis. J. Leukocyte Biol. 75: 76-86.
88. Ueno, Y., S. Tanaka, M. Sumii, S. Miyake, S. Tazuma, M. Taniguchi, T. Yamamura, and K. Chayama. 2005. Single dose of OCH improves mucosal T helper type 1/T helper type 2 cytokine balance and prevents experimental colitis in the presence of vα14 natural killer T cells in mice. Inflamm. Bowel Dis. 11: 35-41.
89. 4 integrin antibodies aggravates colitis in Gαi2-deficient mice. Eur. J. Immunol. 35: 2274-2283.
90. D'Orazio, T. J., E. Mayhew, and J. Y. Niederkorn. 2001. Ocular immune privilege promoted by the presentation of peptide on tolerogenic B cells in the spleen. II. Evidence for presentation by Qa-1. J. Immunol. 166: 26-32.
91. Bolland, S. 2005. A newly discovered Fc receptor that explains IgG-isotype disparities in effector responses. Immunity 23: 2-4.
92. Kalergis, A. M., and J. V. Ravetch. 2002. Inducing tumor immunity through the selective engagement of activating Fcγ receptors on dendritic cells. J. Exp. Med. 195: 1653-1659.
93. Legge, K. L., R. K. Gregg, R. Maldonado-Lopez, L. Li, J. C. Caprio, M. Moser, and H. Zaghouani. 2002. On the role of dendritic cells in peripheral T cell tolerance and modulation of autoimmunity. J. Exp. Med. 196: 217-227.
94. Bayry, J., S. Lacroix-Demazes, M. D. Kazatchkine, O. Hermine, D. F. Tough, and S. V. Kaveri. 2005. Modulation of dendritic cell maturation and function by B lymphocytes. J. Immunol. 175: 15-20.
95. + T cell-mediated granulomatous pathology in schistosomiasis is down-regulated by a B cell-dependent mechanism requiring Fc receptor signalling. J. Exp. Med. 187: 619-629.
96. Bruhns, P., A. Samuelsson, J. W. Pollard, and J. V. Ravetch. 2003. Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease. Immunity 18: 573-581.
97. Siragam, V., D. Brinc, A. R. Crow, S. Song, J. Freedman, and A. H. Lazarus. 2005. Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease? J. Clin. Invest. 115: 155-160.
98. Mizoguchi, A., E. Mizoguchi, S. Tonegawa, and A. K. Bhan. 1996. Alteration of a polyclonal to an oligoclonal immune response to cecal aerobic bacterial antigens in TCR-α mutant mice with inflammatory bowel disease. Int. Immunol. 8: 1387-1394.
99. Casciola-Rosen, L. A., G. Anhalt, and A. Rosen. 1994. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179: 1317-1330.
100. Huggins, M. L., I. Todd, M. A. Cavers, S. R. Pavuluri, P. J. Tighe, and R. J. Powell. 1999. Antibodies from systemic lupus erythematosus (SLE) sera define differential release of autoantigens from cell lines undergoing apoptosis. Clin. Exp. Immunol. 118: 322-328.
101. Savill, J., V. Fadok, P. Henson, and C. Haslett. 1993. Phagocyte recognition of cells undergoing apoptosis. Immunol. Today 14: 131-136.
102. Bellone, M. 2000. Apoptosis, cross-presentation, and the fate of the antigen specific immune response. Apoptosis 5: 307-314.
103. Lodes, M. J., Y. Cong, C. O. Elson, R. Mohamath, C. J. Landers, S. R. Targan, M. Fort, and R. M. Hershberg. 2004. Bacterial flagellin is a dominant antigen in Crohn's disease. J. Clin. Invest. 113: 1296-1306.
104. Smelt, S. C., S. E. Cotterell, C. R. Engwerda, and P. M. Kaye. 2000. B cell-deficient mice are highly resistant to Leishmania donovani infection, but develop neutrophil-mediated tissue pathology. J. Immunol. 164: 3681-3670.